Literature DB >> 12767331

Preparation of vitamin K-dependent proteins, such as clotting factors II, VII, IX and X and clotting inhibitor protein C.

Djuro Josic1, Lutz Hoffer, Andrea Buchacher.   

Abstract

A review is given of preparative methods for the isolation of the vitamin K-dependent clotting factors II, VII, IX, X and clotting inhibitor protein C, all derived from human plasma. Factor II, activated factor VII and activated protein C are also obtained from recombinant animal cells. The methods for their purification are described. The problem of difference in posttranslational modifications between plasma derived and recombinant protein is discussed with regard to therapeutic proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12767331     DOI: 10.1016/s1570-0232(03)00082-5

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  9 in total

Review 1.  The role of proteomics in plasma fractionation and quality control of plasma-derived therapeutic proteins.

Authors:  Dajana Gaso-Sokac; Djuro Josic
Journal:  Blood Transfus       Date:  2010-06       Impact factor: 3.443

2.  Selectivity of monolithic supports under overloading conditions and their use for separation of human plasma and isolation of low abundance proteins.

Authors:  Marija Brgles; James Clifton; Robert Walsh; Feilei Huang; Marijana Rucevic; Lulu Cao; Douglas Hixson; Egbert Müller; Dj Josic
Journal:  J Chromatogr A       Date:  2010-12-03       Impact factor: 4.759

3.  Procoagulant activities of skeletal and cardiac muscle myosin depend on contaminating phospholipid.

Authors:  Valerie A Novakovic; Gary E Gilbert
Journal:  Blood       Date:  2020-11-19       Impact factor: 22.113

Review 4.  Sample displacement chromatography as a method for purification of proteins and peptides from complex mixtures.

Authors:  Martina Srajer Gajdosik; James Clifton; Djuro Josic
Journal:  J Chromatogr A       Date:  2012-03-30       Impact factor: 4.759

5.  Proteomic analysis for process development and control of therapeutic protein separation from human plasma.

Authors:  Xinli Yang; James Clifton; Feilei Huang; Spomenka Kovac; Douglas C Hixson; Djuro Josic
Journal:  Electrophoresis       Date:  2009-04       Impact factor: 3.535

6.  Separation of proteins from human plasma by sample displacement chromatography in hydrophobic interaction mode.

Authors:  Djuro Josic; Lucas Breen; James Clifton; Martina Srajer Gajdosik; Dajana Gaso-Sokac; Marijana Rucevic; Egbert Müller
Journal:  Electrophoresis       Date:  2012-07       Impact factor: 3.535

7.  Use of proteomics for validation of the isolation process of clotting factor IX from human plasma.

Authors:  James Clifton; Feilei Huang; Dajana Gaso-Sokac; Kate Brilliant; Douglas Hixson; Djuro Josic
Journal:  J Proteomics       Date:  2009-10-09       Impact factor: 4.044

Review 8.  Updates on the clinical evidenced herb-warfarin interactions.

Authors:  Beikang Ge; Zhen Zhang; Zhong Zuo
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-18       Impact factor: 2.629

9.  Two-Step Size-Exclusion Nanofiltration of Prothrombin Complex Concentrate Using Nanocellulose-Based Filter Paper.

Authors:  Levon Manukyan; Athanasios Mantas; Mikhail Razumikhin; Andrey Katalevsky; Eugen Golubev; Albert Mihranyan
Journal:  Biomedicines       Date:  2020-03-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.